SIAG
AMRX icon

Safeguard Investment Advisory Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Safeguard Investment Advisory Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,924
Closed -$8K – 104
2020
Q4 		$8K Buy
+1,924
New +$8.53K 0.01% 442

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Safeguard Investment Advisory Group's AMRX Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of Amneal Pharmaceuticals (AMRX) in Q1 2021, closing a stake of 1,924 shares — an estimated $8K sold.

Safeguard Investment Advisory Group first reported a position in AMRX in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 161 funds tracked by Wall St. Rank hold AMRX as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining Amneal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 1,924 Amneal Pharmaceuticals shares in Q1 2021, an estimated $8K.
  • Safeguard Investment Advisory Group first reported a position in Amneal Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's Amneal Pharmaceuticals position peaked at $8K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.